President Donald Trump has warned a group of major U.S. drugmakers that his administration is set to impose tariffs on pharmaceutical goods, and they should start moving their manufacturing businesses ...

Fabry Disease Clinical Trial Pipeline Major pharmaceutical companies are working to advance the pipeline space and unlock the future growth ...

As LB Pharmaceuticals enters a pivotal stage of growth, the additions of Gad and Richard to our leadership team reinforce our ability to execute on our ambitious clinical and regulatory goals,” said ...

How many shows has David Shire written? David Shire has written 16 shows including The Sap of Life (Composer), The Sap of Life (Composer), How Do You Do, I Love You (Composer), Love Match ...

Leading Sheffield-based pharmaceutical company, B. Braun Medical, announces that its HR Director, Helene Ghosh, has been honoured with the title of Freeman of the Company of Cutlers in Hallamshire ...

Leading Sheffield-based pharmaceutical company, B. Braun Medical, announces that its HR Director, Helene Ghosh, has been honoured with the title of Freeman of the Company of Cutlers in Hallamshire ...

LONDON: US drugmaker AbbVie raised its offer for Shire to £30.1bil (US$51.3bil ... specialist had said fundamentally undervalued the company. Cancel anytime. No ads. Auto-renewal.

Neimeth International Pharmaceuticals also faced significant challenges, reporting a forex loss of N2.03 billion in 2024, an increase from the N1.26 million forex loss in the previous year. The ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--#commercial--Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Brad Leonard as Vice President, Generics ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

During his tenure as Takeda’s first non-Japanese CEO, Weber expanded the company's international reach with its $62 billion acquisition of Shire. It was through that deal that Kim joined Takeda.

Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co ... subject to shareholder approval, the company said in a statement Wednesday.